Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review

REFERENCES

• Bachmann GA. The clinical platform for the 17-beta- estradiol vaginal releasing ring. Am J Obstet Gynecol 1998;178:8257–60
   Google Scholar
• Shaupe D. HRT dosing regimens: continuous versus cyclic – pros and cons. Int J Fertil 2001;46:7–15
   Google Scholar
• Henriksson L, Stjernquist M, Boquist L, Cedergren I, Selinus I. A one-year multi-centre study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85–92
   PubMed Web of Science ®Google Scholar
• Smith P. Estrogen and the urogenital tract: studies on estradiol hormone receptors and a clinical study on a new estradiol releasing vaginal ring. Acta Obstet Gynecol Scand 1993; 72(Suppl 157): 1–26
   Google Scholar
• Eriksen B. A randomised, open, parallel-group study on the preventive effect of an estradiol releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180:1072–9
   PubMed Web of Science ®Google Scholar
• Schmidt G, Andersson SB, Nordle O, Johansson CJ, Gunersson PO. Release of 17-beta estradiol from a vaginal ring in postmenopausal women: pharmaco- kinetic evaluation. Gynecol Obstet Invest 1994;38:253–60
   PubMed Web of Science ®Google Scholar
• Smith P, Heimer G, Lindskog M, Ulmsten U. Estradiol releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitus 1993;16:145–54
   PubMed Web of Science ®Google Scholar
• Holmgren PA, Lindskog M, von Schoulz B. Vaginal ring for continuous low-dose release of estradiol in the treatment of urinogenital atrophy. Maturitus 1989;11:55–63
   PubMed Web of Science ®Google Scholar
• Gabrielsson J, Wallenbeck Z, Birgerson L. The pharma- cokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics. Acta Obstet Gynecol Scand 1996; 75(Suppl 163): 26–31
   Google Scholar
• Johnston A. Estrogen – pharmacokinetics and pharma- codynamics with a special reference to vaginal administration and the new estradiol formulation – EstringÒ Acta Obstet Gynecol Scand 1996; 75(Suppl 163): 16–25
   Google Scholar
• Lose G, Englev K. Estradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000;107:1029–34
   Google Scholar
• Casper F, Petri K, Benninghoff B. Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study. Zentralbl Gynakol 1998;120:449–53
   PubMedGoogle Scholar
• Barentsen R, van de Weijer PH, Schram JH. Con- tinuous low-dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73–80
   PubMed Web of Science ®Google Scholar
• Ayton RA, Darling GM, Murkies AL, et al. A compara- tive study of safety and efficacy of continuous low-dose estradiol released from a vaginal ring compared with conjugated equine estrogen vaginal cream in the treat- ment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 1996;103:351–8
   PubMedGoogle Scholar
• Bachmann G. Estradiol releasing vaginal ring delivery system for urogenital atrophy. Experience over past decade. J Reprod Med 1998;43:991–8
   PubMed Web of Science ®Google Scholar
• Buckler H, Al-Azzawi F, UK-VR Multi-centre trial group. The effect of a novel vaginal ring delivering estradiol acetate on climacteric symptoms in postmeno- pausal women. Br J Obstet Gynaecol 2003;110:753–9
   Google Scholar
• Al-Azzawi F, Buckler H, UK-VR trial group. Com- parison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms. Climacteric 2003;6:118–27
   PubMed Web of Science ®Google Scholar
• Hamada AL, Maruo T, Samoto T, et al. Estradiol/ progesterone releasing vaginal rings for hormone replacement therapy in postmenopausal women. Gynecol Endocrinol 2003;17:247–54
   PubMed Web of Science ®Google Scholar
• Botsis D, Kassanos D, Kalogirou D, Antoniou G, Karakitsos P, Zourlas PA. A comparative study of an estradiol-releasing vaginal ring versus tibolone in post- menopausal women: a transvaginal colour Doppler study. Maturitus 1997;27:77–93
   PubMed Web of Science ®Google Scholar
• Antoniou G, Kalogirou D, Karakitsos P, Antoniou D, Kalogirou O, Giannikos L. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses. Maturitus 1997; 26:103–11
   PubMed Web of Science ®Google Scholar
• Kalogirou D, Antoniou G, Karakitsos P, Kalogirou O, Antoniou D, Giannikos L. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestogen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Int J Fertil Menopausal Study 1996;41:522–7
   PubMed Web of Science ®Google Scholar
• Weisberg E, Fraser I-S, Baker J, et al. A randomised comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of ring. Contraception 2000;62:83–9
   PubMed Web of Science ®Google Scholar
• Naessen T, Rodriguez-Macias K, Lithel H. Serum lipid profile improved by ultra-low doses of 17-beta- estradiol in elderly women. J Clin Endocrinol Metab 2001;86:2757–62
   PubMed Web of Science ®Google Scholar
• Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multi-center study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in post- menopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 1994;171:624–32
   PubMed Web of Science ®Google Scholar
• Casper F, Petri E. Local treatment of urogenital atrophy with an estradiol releasing vaginal ring: a comparative and placebo-controlled multi-centre study. Vaginal ring group. Int Urogynecol Pelvic Floor Dysfunct 1999; 10:171–6
   PubMedGoogle Scholar